Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-25 @ 1:23 AM
NCT ID:
NCT05410093
Eligibility Criteria:
Inclusion Criteria:
1. Amenorrhea or oligomenorrhea at least 4 months and two (\>4 weeks interval) basal FSH≥10mIU/ml；
2. The women aged \<40 years old；
3. Informed consent, voluntary experiment.
Exclusion Criteria:
1. Pregnant and lactating patients;
2. Patients with endometriosis, adenomyosis, endometrial lesions (submucosal fibroids, endometrial polyps, etc.), uterine fibroids\>4 cm or hysterectomy;
3. Patients with adrenal cortical hyperplasia or tumour；
4. Ovarian neoplasms patients；
5. Hydrosalpinx patients；
6. Hyperprolactinemia patients；
7. Patients who are participating in other clinical trials or have participated in other clinical trials within the past three months;
8. Patients with a suspected or real history of alcohol and drug abuse;
9. Known allergy to the investigational drug or its components;
10. Other patients were deemed unsuitable for participation in this trial by the investigator.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT05410093
Study Brief:
Protocol Section:
NCT05410093